HbA1c Testing Market Expected to Grow Steadily to $3.31B by 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Hemoglobin A1c (HbA1c) Testing Market Progress Between 2026 And 2030?
The hemoglobin a1c (hba1c) testing market size has seen swift expansion in recent years. It is anticipated to increase from $2.02 billion in 2025 to $2.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. This growth observed in the past can be ascribed to the increasing global prevalence of diabetes, the greater implementation of long-term glucose monitoring, the expansion of diagnostic laboratory infrastructure, heightened awareness regarding diabetes screening, and the widespread adoption of hba1c as a diagnostic standard.
The hemoglobin a1c (hba1c) testing market size is projected to experience substantial growth over the coming years. This market is forecast to reach $3.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. The expansion during this forecast period can be attributed to several factors, including the increasing use of home-based diabetes monitoring, greater investments in connected diagnostic devices, the broadening of preventive healthcare programs, a heightened emphasis on early diabetes detection, and a rising need for swift diagnostic solutions. Key trends anticipated in the upcoming period involve the growing acceptance of point-of-care hba1c testing instruments, an increasing demand for portable and home-use hba1c analyzers, the expanding integration of wireless and connected testing methods, advancements in high-accuracy laboratory-based hba1c technologies, and a reinforced commitment to standardization and diagnostic precision.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report
What Key Factors Are Shaping The Hemoglobin A1c (HbA1c) Testing Market Landscape?
The escalating incidence of diabetes is projected to fuel the expansion of the hemoglobin A1c (HbA1c) testing market in the coming years. Diabetes is a persistent medical condition where the body struggles to properly regulate blood glucose levels due to either insufficient insulin production or insulin resistance. The rise in diabetes cases can be attributed to poor dietary habits, notably a high intake of processed foods and sugary beverages, and inactive lifestyles characterized by minimal physical exertion. Furthermore, an aging population and a family history of diabetes heighten the probability of developing the condition. HbA1c testing is employed to monitor long-term blood glucose control in individuals with diabetes by measuring the average blood sugar level over the preceding 2–3 months. As an illustration, in June 2023, data published by The Lancet, a UK-based book and periodic data publishing organization, indicated that global diabetes cases are expected to surge from 529 million in 2021 to 1.3 billion by 2050. Thus, the growing prevalence of diabetes will stimulate the growth of the hemoglobin A1c (HbA1c) testing market.
Which Segment Types Are Examined In The Hemoglobin A1c (HbA1c) Testing Market Segment Study?
The hemoglobin a1c (hba1c) testing market covered in this report is segmented –
1) By Testing Method: Laboratory-Based Testing, Point Of Care (PoC) Testing
2) By Product Type: Instruments, Reagents, Kits
3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings
Subsegments:
1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis
2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits
What Market Trends Are Affecting The Hemoglobin A1c (HbA1c) Testing Market?
Major companies within the hemoglobin A1c (HbA1c) testing market are concentrating on technological improvements in diagnostic testing, specifically HbA1c home tests, to deliver more convenient, accurate, and accessible options for early diabetes detection and its management. HbA1c home tests are at-home diagnostic kits that enable individuals to measure their average blood sugar levels from the past 2-3 months, aiding in the monitoring and management of diabetes. For instance, in February 2023, Hurdle Health, a US-based company dedicated to offering innovative healthcare solutions, including diagnostic tools for chronic disease management, introduced the Hemoglobin A1c (HbA1c) Test. This new test, performed with an at-home blood sample, allows adults to screen for and monitor diabetes, advancing Chronomics’ goal to improve access to diagnostic testing and enhance health outcomes through direct-to-consumer solutions.
Which Players Are Part Of The Competitive Landscape Of The Hemoglobin A1c (HbA1c) Testing Market?
Major companies operating in the hemoglobin a1c (hba1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH
Get The Full Hemoglobin A1c (HbA1c) Testing Market Report:
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report
Which Geographic Region Dominates The Hemoglobin A1c (HbA1c) Testing Market?
North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin a1c (hba1c) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hemoglobin A1c (HbA1c) Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report
Browse Through More Reports Similar to the Global Hemoglobin A1c (HbA1c) Testing Market 2026, By The Business Research Company
Poc Hba1C Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report
Hemoglobin A1C Testing Devices Market Report 2026
Hemoglobin Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
